Condition
Rejection Acute Renal
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Unknown2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04166149Completed
Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA
NCT05483725Active Not Recruiting
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
NCT03134625Unknown
Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation
NCT04292418UnknownPrimary
Predictors of Rejection in Pediatric Kidney Transplantation
NCT03317925Completed
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Showing all 5 trials